MRI of Intracranial Atherosclerosis
MRI of Intracranial Atherosclerosis
批准号:
8424218
负责人:
Ye Qiao
金额:
$8.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-02-09 至 2014-01-31
关键词:
3-DimensionalAgeAngiographyArterial Fatty StreakAtherosclerosisBlood PressureBlood VesselsBrainCardiovascular DiseasesClinical ResearchCommunitiesDevelopmentDiabetes MellitusDiagnosticDiseaseEnvironmentEpidemiologyEventFundingGrantHemorrhageHigh Density Lipoprotein CholesterolHigh PrevalenceHospitalsImageIndividualIntracranial AtherosclerosesIschemic StrokeKnowledgeLeadLesionLipidsMagnetic Resonance ImagingMeasurementMeasuresMentorsMethodologyMorphologyNeurocognitiveNeurologyParticipantPathologyPatientsPersonsPhasePhysicsPrevalenceRaceResearchResearch InfrastructureResolutionRiskRisk FactorsSamplingScheduleSmokingStenosisStrokeStroke preventionTechniquesThickTrainingUnited States National Institutes of HealthWorkagedarterial remodelingdisease diagnosisimprovedin vivoinflammatory markerinstrumentationmiddle agenovelpopulation basedsextoolvascular bedvascular factor
中文摘要
描述(申请人提供):美国每年发生超过780,000例中风,其中至少125,000例与颅内动脉粥样硬化(ICAD)直接相关。尽管ICAD带来了重要后果,但其流行率仍不清楚。传统的ICAD诊断依赖于血管造影术测量的狭窄程度;然而,在其他血管床中,当血管通过重塑适应斑块时,管腔狭窄不是斑块负荷的不良指标。最近,使用高分辨率磁共振成像在颅外斑块中显示了不依赖管腔评估而在体内检测和表征斑块的能力。我们建议开发高分辨率MRI技术来表征ICAD的独特特征。这将在NIH资助的一项基于人群的研究中实施,该研究名为社区动脉粥样硬化风险神经认知研究(ARIC-NCS),旨在调查ICAD在美国的患病率以及导致其发展和中风的因素。在这笔赠款的K99培训阶段,我将
由一支具有神经放射学、神经学、病理学、核磁共振物理学和流行病学专业知识的杰出导师团队监督。培训将通过课程作业、辅导性研究和进度评估进行。我的指导研究的主要目标是确定ICAD的患病率,并检查ICAD狭窄和负担与危险因素和血管标志物的关系。在独立阶段(R00),我将应用从第一个授权期(K99)获得的知识来确定ICAD斑块成分的特征,并确定这些成分与缺血性中风的相关性。我的总体假设是,高分辨率磁共振血管壁和斑块成像将提高我们对中风风险分层的能力,从而使初级中风预防和治疗的新策略成为可能。约翰霍普金斯大学的培训环境特别适合这项研究,因为它提供了使用最先进的仪器和基础设施的途径,并拥有长期支持临床研究的记录。相关性:用于表征颅内动脉粥样硬化斑块形态和成分的新的MRI方法将对缺血事件和病变进展的风险进行分层。从动脉粥样硬化的高分辨率磁共振成像中获得的信息对于改进初级卒中预防和治疗的策略是有价值的。
英文摘要
DESCRIPTION (provided by applicant): Over 780,000 strokes occur annually in the U.S. with at least 125,000 directly related to intracranial atherosclerosis (ICAD). Despite the important consequences of ICAD, its prevalence remains unclear. Traditional ICAD diagnosis has depended on stenosis measured by angiography; however, in other vascular beds, lumen narrowing is a poor indicator of plaque burden when vessels accommodate plaques by remodeling. The ability to detect and characterize plaque in vivo without relying on lumen assessment has recently been shown in extracranial plaque using high-resolution MRI. We propose to develop high-resolution MRI techniques to characterize the unique features of ICAD. This will be implemented in an NIH-funded population-based study, the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS), to investigate ICAD prevalence in the US and factors that lead to its development and stroke. In the K99 training phase of this grant, I will be
supervised by an outstanding team of mentors with expertise in neuroradiology, neurology, pathology, MRI physics and epidemiology. Training will be conducted via course work, mentored research, and progress reviews. The major objective of my mentored research is to determine ICAD prevalence, and examine ICAD stenosis and burden in relation to risk factors and vascular markers. In the independent phase (R00), I will apply knowledge gained from the first grant period (K99) to characterize ICAD plaque components and determine associations of these components with ischemic stroke. My overall hypothesis is that high- resolution MRI vessel wall and plaque imaging will improve our ability to stratify stroke risk, thereby enabling new strategies for primary stroke prevention and treatment. The training environment at Johns Hopkins is especially well-suited for this research since it offers access to state-of-the art instrumentation and an infrastructure with a long track-record of supporting clinical research. Relevance: New MRI methodologies for characterizing intracranial atherosclerotic plaque morphology and composition will stratify risk for ischemic events and lesion progression. Information obtained from high resolution MRI of atherosclerosis can be valuable in refining strategies for primary stroke prevention and treatment.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Intracranial plaque enhancement in patients with cerebrovascular events on high-spatial-resolution MR images.
高间隙 - 分辨率MR图像上脑血管事件患者的颅内斑块增强。
DOI:
10.1148/radiol.13122812
发表时间:
2014-05
期刊:
Radiology
影响因子:
19.7
作者:
[Qiao Y, Zeiler SR, Mirbagheri S, Leigh R, Urrutia V, Wityk R, Wasserman BA]
通讯作者:
Wasserman BA
DOI:
10.3174/ajnr.a2863
发表时间:
2012-04
期刊:
AJNR. American journal of neuroradiology
影响因子:
--
作者:
[Qiao Y, Etesami M, Astor BC, Zeiler SR, Trout HH 3rd, Wasserman BA]
通讯作者:
Wasserman BA
MRI of Intracranial Atherosclerosis
-
批准号:8896020
-
项目类别:
-
资助金额:$24.5万
-
财政年份:2012
-
负责人:Ye Qiao
-
依托单位:
MRI of Intracranial Atherosclerosis
-
批准号:8788317
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2012
-
负责人:Ye Qiao
-
依托单位:
MRI of Intracranial Atherosclerosis
-
批准号:8242387
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2012
-
负责人:Ye Qiao
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: